{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T16:41:53Z","timestamp":1770741713547,"version":"3.49.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T00:00:00Z","timestamp":1766102400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jacc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["JACC: Cardiovascular Interventions"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/j.jcin.2025.11.028","type":"journal-article","created":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T19:30:31Z","timestamp":1770665431000},"page":"359-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Major Bleeding Risk Assessment With Atrial Fibrillation Post-TAVR"],"prefix":"10.1016","volume":"19","author":[{"given":"George D.","family":"Dangas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Unverdorben","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Hengstenberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5546-262X","authenticated-orcid":false,"given":"Roxana","family":"Mehran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ra\u00fal","family":"Moreno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3438-8907","authenticated-orcid":false,"given":"Luis","family":"Nombela-Franco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Kimura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diego","family":"L\u00f3pez-Otero","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2560-4068","authenticated-orcid":false,"given":"Peter","family":"Nordbeck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2297-5303","authenticated-orcid":false,"given":"Yusuke","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0847-5329","authenticated-orcid":false,"given":"Hyo-Soo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johny","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Johanna","family":"van Zyl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8018-2857","authenticated-orcid":false,"given":"St\u00e9phane","family":"Noble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicolas M.","family":"Van Mieghem","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.jcin.2025.11.028_bib1","doi-asserted-by":"crossref","first-page":"836","DOI":"10.21470\/1678-9741-2020-0538","article-title":"Risk of bleeding after transcatheter aortic valve replacement: impact of preoperative antithrombotic regimens","volume":"37","author":"Albabtain","year":"2022","journal-title":"Braz J Cardiovasc Surg"},{"issue":"21","key":"10.1016\/j.jcin.2025.11.028_bib2","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/j.jacc.2020.09.595","article-title":"STS-ACC TVT Registry of Transcatheter Aortic Valve Replacement","volume":"76","author":"Carroll","year":"2020","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jcin.2025.11.028_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1536\/ihj.15-195","article-title":"Incidence, predictors and impact of severe periprocedural bleeding according to VARC-2 criteria on 1-year clinical outcomes in patients after transcatheter aortic valve implantation","volume":"57","author":"Kochman","year":"2016","journal-title":"Int Heart J"},{"issue":"7","key":"10.1016\/j.jcin.2025.11.028_bib4","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1093\/eurheartj\/ehab395","article-title":"2021 ESC\/EACTS guidelines for the management of valvular heart disease","volume":"43","author":"Vahanian","year":"2022","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.jcin.2025.11.028_bib5","doi-asserted-by":"crossref","first-page":"2951","DOI":"10.1016\/j.jcin.2023.10.011","article-title":"Bleeding in patients undergoing transfemoral transcatheter aortic valve replacement: incidence, trends, clinical outcomes, and predictors","volume":"16","author":"van Nieuwkerk","year":"2023","journal-title":"JACC Cardiovasc Interv"},{"issue":"19","key":"10.1016\/j.jcin.2025.11.028_bib6","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1056\/NEJMoa1400590","article-title":"Transcatheter aortic-valve replacement with a self-expanding prosthesis","volume":"370","author":"Adams","year":"2014","journal-title":"N Engl J Med"},{"issue":"17","key":"10.1016\/j.jcin.2025.11.028_bib7","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1056\/NEJMoa1514616","article-title":"Transcatheter or surgical aortic-valve replacement in intermediate-risk patients","volume":"374","author":"Leon","year":"2016","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.jcin.2025.11.028_bib8","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1056\/NEJMoa1814052","article-title":"Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients","volume":"380","author":"Mack","year":"2019","journal-title":"N Engl J Med"},{"issue":"18","key":"10.1016\/j.jcin.2025.11.028_bib9","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.1056\/NEJMoa1816885","article-title":"Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients","volume":"380","author":"Popma","year":"2019","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.jcin.2025.11.028_bib10","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/j.jcin.2022.01.018","article-title":"New-onset atrial fibrillation after transcatheter aortic valve replacement: a systematic review and meta-analysis","volume":"15","author":"Ryan","year":"2022","journal-title":"JACC Cardiovasc Interv"},{"issue":"23","key":"10.1016\/j.jcin.2025.11.028_bib11","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1056\/NEJMoa2111016","article-title":"Edoxaban versus vitamin K antagonist for atrial fibrillation after TAVR","volume":"385","author":"Van Mieghem","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jcin.2025.11.028_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ahj.2018.07.006","article-title":"Edoxaban versus standard of care and their effects on clinical outcomes in patients having undergone transcatheter aortic valve implantation in atrial fibrillation-rationale and design of the ENVISAGE-TAVI AF trial","volume":"205","author":"Van Mieghem","year":"2018","journal-title":"Am Heart J"},{"issue":"4","key":"10.1016\/j.jcin.2025.11.028_bib13","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1538-7836.2005.01204.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in non-surgical patients","volume":"3","author":"Schulman","year":"2005","journal-title":"J Thromb Haemost"},{"issue":"1","key":"10.1016\/j.jcin.2025.11.028_bib14","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/j.1538-7836.2009.03678.x","article-title":"Definition of major bleeding in clinical investigations of antihemostatic medicinal products in surgical patients","volume":"8","author":"Schulman","year":"2010","journal-title":"J Thromb Haemost"},{"issue":"10","key":"10.1016\/j.jcin.2025.11.028_bib15","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/sim.1742","article-title":"Presentation of multivariate data for clinical use: the Framingham Study risk score functions","volume":"23","author":"Sullivan","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/j.jcin.2025.11.028_bib16","series-title":"Regression Modeling Strategies: With Applications to Linear Models, Logistic and Ordinal Regression, and Survival Analysis","author":"Harrell","year":"2015"},{"key":"10.1016\/j.jcin.2025.11.028_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0169-7161(03)23001-7","article-title":"Evaluation of the performance of survival analysis models: discrimination and calibration measures","volume":"23","author":"D\u2019Agostino","year":"2003","journal-title":"Handbook Stat"},{"issue":"10","key":"10.1016\/j.jcin.2025.11.028_bib18","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1056\/NEJMoa1009638","article-title":"Rivaroxaban versus warfarin in nonvalvular atrial fibrillation","volume":"365","author":"Patel","year":"2011","journal-title":"N Engl J Med"},{"issue":"11","key":"10.1016\/j.jcin.2025.11.028_bib19","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1056\/NEJMoa1107039","article-title":"Apixaban versus warfarin in patients with atrial fibrillation","volume":"365","author":"Granger","year":"2011","journal-title":"N Engl J Med"},{"issue":"8","key":"10.1016\/j.jcin.2025.11.028_bib20","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jacc.2022.11.057","article-title":"Clinical evaluation of factor XIa inhibitor drugs: JACC review topic of the week","volume":"81","author":"Harrington","year":"2023","journal-title":"J Am Coll Cardiol"},{"issue":"8","key":"10.1016\/j.jcin.2025.11.028_bib21","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/MBC.0b013e32801010b7","article-title":"Ethanol impairs coagulation and fibrinolysis in whole blood: a study performed with rotational thromboelastometry","volume":"17","author":"Engstrom","year":"2006","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"22","key":"10.1016\/j.jcin.2025.11.028_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.013703","article-title":"Prognostic impact of baseline hemoglobin levels on long-term thrombotic and bleeding events after percutaneous coronary interventions","volume":"8","author":"Nagao","year":"2019","journal-title":"J Am Heart Assoc"},{"issue":"38","key":"10.1016\/j.jcin.2025.11.028_bib23","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1093\/eurheartj\/ehu175","article-title":"Advanced chronic kidney disease in patients undergoing transcatheter aortic valve implantation: insights on clinical outcomes and prognostic markers from a large cohort of patients","volume":"35","author":"Allende","year":"2014","journal-title":"Eur Heart J"},{"issue":"1","key":"10.1016\/j.jcin.2025.11.028_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s40256-022-00555-4","article-title":"Statins reduce bleeding risk in patients taking oral anticoagulants for nonvalvular atrial fibrillation: a retrospective registry study","volume":"23","author":"Uchida","year":"2023","journal-title":"Am J Cardiovasc Drugs"},{"issue":"3","key":"10.1016\/j.jcin.2025.11.028_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s00392-024-02379-5","article-title":"Outcomes after TAVI in patients with atrial fibrillation and a history of recent PCI: results from the ENVISAGE-TAVI AF trial","volume":"114","author":"Moreno","year":"2025","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.jcin.2025.11.028_bib26","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.carrev.2020.08.011","article-title":"Anticoagulation with or without antiplatelet therapy following transcatheter aortic valve replacement for patients with atrial fibrillation: a meta-analysis","volume":"24","author":"Yokoyama","year":"2021","journal-title":"Cardiovasc Revasc Med"},{"issue":"16","key":"10.1016\/j.jcin.2025.11.028_bib27","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1161\/CIRCULATIONAHA.121.054305","article-title":"Antithrombotic therapy in patients undergoing transcatheter interventions for structural heart disease","volume":"144","author":"Calabro","year":"2021","journal-title":"Circulation"},{"issue":"1","key":"10.1016\/j.jcin.2025.11.028_bib28","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.jacc.2023.08.017","article-title":"2023 ACC\/AHA\/ACCP\/HRS guideline for the diagnosis and management of atrial fibrillation: a report of the American College of Cardiology\/American Heart Association joint committee on clinical practice guidelines","volume":"83","author":"Joglar","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"36","key":"10.1016\/j.jcin.2025.11.028_bib29","doi-asserted-by":"crossref","first-page":"3314","DOI":"10.1093\/eurheartj\/ehae176","article-title":"2024 ESC guidelines for the management of atrial fibrillation developed in collaboration with the European Association for Cardio-Thoracic Surgery (EACTS)","volume":"45","author":"Van Gelder","year":"2024","journal-title":"Eur Heart J"},{"issue":"3","key":"10.1016\/j.jcin.2025.11.028_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022478","article-title":"Risk factors for thromboembolic and bleeding events in anticoagulated patients with atrial fibrillation: the prospective, multicentre observational PREvention oF thromboembolic events\u2014European Registry in Atrial Fibrillation (PREFER in AF)","volume":"9","author":"Rohla","year":"2019","journal-title":"BMJ Open"},{"issue":"11","key":"10.1016\/j.jcin.2025.11.028_bib31","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1016\/j.jcin.2021.03.024","article-title":"Development and validation of a practical model to identify patients at risk of bleeding after TAVR","volume":"14","author":"Navarese","year":"2021","journal-title":"JACC Cardiovasc Interv"}],"container-title":["JACC: Cardiovascular Interventions"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879825031772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1936879825031772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,2,9]],"date-time":"2026-02-09T19:31:01Z","timestamp":1770665461000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1936879825031772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S1936879825031772"],"URL":"https:\/\/doi.org\/10.1016\/j.jcin.2025.11.028","relation":{},"ISSN":["1936-8798"],"issn-type":[{"value":"1936-8798","type":"print"}],"subject":[],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Major Bleeding Risk Assessment With Atrial Fibrillation Post-TAVR","name":"articletitle","label":"Article Title"},{"value":"JACC: Cardiovascular Interventions","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jcin.2025.11.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier on behalf of the American College of Cardiology Foundation.","name":"copyright","label":"Copyright"}]}}